Joana Justino

Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy

J. Wetzels, G. Lambeau, H. Debiec, 2021, Kidney international reports.

Survivin and Smac/DIABLO: role of apoptosis in experimental PAH

Joana Justino, 2013 .

The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy.

J. Wetzels, G. Lambeau, J. Egido, 2020, Kidney international.

Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy.

J. Wetzels, G. Ghiggeri, G. Lambeau, 2019, Kidney international.

HMGB1 down‐regulation mediates terameprocol vascular anti‐proliferative effect in experimental pulmonary hypertension

Ana Filipa Silva, A. Leite-Moreira, R. Vitorino, 2017, Journal of Cellular Physiology.

Signaling pathways underlying skeletal muscle wasting in experimental pulmonary arterial hypertension.

Ana Filipa Silva, J. Duarte, A. Leite-Moreira, 2015, Biochimica et biophysica acta.

Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy.

M. Prunotto, F. Scolari, G. Ghiggeri, 2020, Clinical journal of the American Society of Nephrology : CJASN.

Ectodomain shedding of PLA2R1 is mediated by the metalloproteases ADAM10 and ADAM17

R. Pardossi-Piquard, C. Payré, Joana Justino, 2024, Journal of Biological Chemistry.